ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2011

Feb 24, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2011-02-22

Reporting Person: Lawrence Cameron William (Principal Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-22	Common Stock	M	1400	$3.00	Acquired	4450	Indirect
2011-02-22	Common Stock	M	475	$3.00	Acquired	950	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-22	Stock Option (right to buy)	$3.00	M	1875	Disposed	2015-12-31	Common (1875)	Direct

Footnotes

F1: 1,875 shares are exercisable on each of December 31, 2009, 2010, 2011 and 2012.